| 000 | 01824 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516223027.0 | ||
| 264 | 0 | _c20150330 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1477-7827 | ||
| 024 | 7 |
_a10.1186/1477-7827-12-66 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArumugam, Arunkumar | |
| 245 | 0 | 0 |
_aThe role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model. _h[electronic resource] |
| 260 |
_bReproductive biology and endocrinology : RB&E _cJul 2014 |
||
| 300 |
_a66 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAging |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAromatase _xchemistry |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xblood |
| 650 | 0 | 4 |
_aDehydroepiandrosterone _xadverse effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHormone Replacement Therapy _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipidemias _xblood |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xblood |
| 650 | 0 | 4 |
_aProgesterone _xadverse effects |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aRecombinant Proteins _xchemistry |
| 650 | 0 | 4 |
_aTestosterone _xadverse effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aLissner, Elaine A | |
| 700 | 1 | _aLakshmanaswamy, Rajkumar | |
| 773 | 0 |
_tReproductive biology and endocrinology : RB&E _gvol. 12 _gp. 66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1477-7827-12-66 _zAvailable from publisher's website |
| 999 |
_c24005889 _d24005889 |
||